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Chrysobacterium gleum is a nonmotile, 
oxidase positive, non-fermentative un-
sporulate Gram-negative bacillus, bacteria 
belonging to the genus Chrysobacterium. 
Infections caused by Chrysobacterium spp 
are usually health care associated and the 
most frequent in immunocompromised 
patients and neonates.
In this report we present a case of a 35-year-
old female patient admitted to the hospital 
for extreme malnutrition and a hepatic le-
sion. Chrysobacterium gleum was isolated 
from tracheal aspirate and blood culture. 
The strain was identified with Microflex 
MALDI Biotyper (Bruker Daltonik, Fre-
mont, CA). The patient was successfully 
treated with piperacillin/tazobactam. Em-
pirical therapy is difficult due to intrinsic 
resistance to most antimicrobials which 
are usually effective against Gram-negative 
bacteria.
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INTRODUCTION
Genus Flavobacterium was identified in 
1923. It comprised yellow pigmented, as-
porogenic Gram-negative bacilli. Since 
then, it had undergone several classifica-
tion changes. . In 1994, it was assigned to a 
new genus Chrysobacterium, belonging to 
the family Flavobacteriaceae. The species 
most frequently associated with human 
infections are: Chrysobacterium meningo-
septicum, Chrysobacterium indologenes, 
Chrysobacterium odoratum, Chrysobac-
terium mutlivorum and Chrysobacterium 
gleum. (1) 
C. gleum is rarely reported in the literature; 
it is predominantly isolated from various 
clinical specimens (urine, sputum, wound 
swab, vaginal swab). In previous reports it 
was not separated from other species in the 
genus Chrysobacterium due to insuficient 
identification or misidentification. (2) 
CASE REPORT
In this report we present a case of a 35-year-
old female patient who was initially hospi-
talized for extreme malnutrition (weight 
25.5 kg, height 163 cm, body mass index 
9.57) and a hepatic lesion. On the third 
day of hospitalization she developed a high 
fever and pneumonia and was transferred 
to the intensive care unit (ICU). Labora-
tory analysis revealed leukopenia (L 0.49 x 
109) (neutro 75.5%, ly 16.2%, mono 8.1%) 
with elevated CRP (164 ng/L).  Respiratory 
insufficiency deteriorated with the devel-
opment of septic shock, which required 
intubation and mechanic ventilation. Af-
ter obtaining microbiological specimens 
empiric therapy was initiated with mero-
penem and linezolid. Klebsiella oxytoca, 
Staphylococcus aureus and Candida cru-
sei were isolated from tracheal aspirate 
and thus kaspofungine was added in the 
therapy. After correction of nutritional sta-
tus, hepatic function recovered and white 
blood cell count increased. After 18 days of 
mechanical ventilation, the patient started 
to breathe spontaneously. Laboratory re-
sults showed the recovery of white blood 
cells and the decrease of inflammatory pa-
rameters.On the 28th day in the ICU the 
development of pulmonary infiltrates was 
noticed as well as elevated temperature. 
C. gleum was isolated from blood culture 
and tracheal aspirate. Empiric therapy with 
piperacillin/tazobactam was administered 
for 12 days. Regression of pulmonary in-
filtrates and clinical improvement were ob-
served after antimicrobial therapy.  On the 
42nd day she was transferred to the gastro-
enterology department for further correc-
tion of nutritional status. The body weight 
of 29.7 kg was achieved before the transfer. 
CHARACTERIZATION OF ANTIMICRO-
BIAL RESISTANCE
The susceptibility to a wide range of an-
tibiotics was determined by E test and 
interpreted according to EUCAST stand-
ards for Gram-negative non-fermentative 
bacteria.  MICs of antibiotics active against 
Gram-positive bacteria were interpreted 
according to EUCAST guidelines for 
Staphylococcus. 
The strain was resistant to imipenem, 
meropenem, vancomycin, daptomycin 
and colistin as shown in Table 1., but it 
was susceptible to ciprofloxacin, cefepime, 
ceftazidime, tigecycline and piperacillin /
tazobactam. 
Combined disk test with meropenem and 
EDTA was positive, indicating the produc-
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tion of metallo-β-lactamases (MBL) (3), 
but negative with clavulanic acid and ceph-
alosporins, indicating the absence of an 
ESBL (extended-spectrum β-lactamases). 
(4) 
The transferability of meropenem resist-
ance was tested by conjugation (broth 
mating method) according to Elwell and 
Falkow using Escherichia coli A15R-re-
sistant to rifampicin as recipient strain (5). 
Meropenem resistance was not transferred 
to E. coli recipient strain. 
PCR was performed to detect blaMBL 
genes (blaVIM, blaIMP, blaGIM, blaSPM) 
(6), but yielded no PCR products and 
thus carbapenem resistance is likely to be 
atributted to the chromosomal metalo-β-
lactamase of the genus Chrysobacterium. 
Table 1. Minimum inhibitory concentra-
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In this report we have presented a patient 
with extreme malnutrition and a hepatic 
lesion. She became immobile due to ex-
treme cahexia. In the hospital she was pro-
vided with the intravascular catheter, uri-
nary catheter and endotracheal tubus and 
was on mechanical ventilation for 18 days. 
In previous reports 80% of the patients had 
polymicrobial infection. In our report, ex-
cept for C. gleum, C. krusei and K. oxytoca 
were isolated from sputum and P. aerugi-
nosa from urine. Our patient stayed in the 
ICU for 28 days and received meropenem 
and linezolid prior to isolation of C. gleum.
C. gleum is an unusual human pathogen. 
Viroca et al. described early neonatal res-
piratory infection due to C. gleum in three 
neonates. (7)  Lo et al. performed for the 
first time a focused study on 15 C. gleum 
isolates. The strains were epidemiologi-
cally unrelated and originated mostly from 
urine and sputum. (2)
The data on antimicrobial susceptibility of 
Chryseobacterium spp are limited due to a 
small number of clinical isolates. Clinical 
microbiologists usually face two problems: 
disk diffusion test is not an adequate meth-
od for testing Chryseobacterium spp and 
there are no standardized breakpoints for 
Chryseobacterium spp in  EUCAST guide-
lines. (8) The choice of an antimicrobial 
drug for the treatment of Chryseobacte-
rium spp infection is difficult because of its 
intrinsic chromosomal resistance to many 
antibiotics used for Gram-negative bacte-
ria. Chryseobacterium spp has intrinsic 
chromosomal resistance to aminoglyco-
sides, meropenem and imipenem. (9) Our 
patient was treated with piperacillin/tazo-
bactam.  The nutritional status of our pa-
tient was also corrected, which improved 
hepatic function. This is in concordance 
with the previous report from Bridget at 
al., who treated a 35-year-old patient with 
anorexia nervosa by rehydration, electro-
lyte correction and nutritional support, 
which also improved hepatic function and 
decreased the transaminases level. (10)
Chryseobacterium spp are the only Gram-
negative bacteria susceptible to vancomy-
cin.  Vancomycin as monotherapy or com-
bined with other antimicrobials including 
rifampicin was successful in the treatment 
of neonatal meningitis. (1) 
CONCLUSION
It is necessary to consider Chryseobacteri-
um spp as causative agent of hospital infec-
tions, particularly in patients hospitalized 
in the ICU for more than 21 days, in those 
who received broad spectrum antibiotics 
and in those with indwelling devices. Em-
piric choice of antimicrobial agent is diffi-
cult because of intrinsic resistance to most 
antibiotics effective against Gram-negative 
bacteria and very often because of the pol-
ymicrobial etiology of infections. Modern 
methods for identification (MALDI-TOF) 
should ensure a fast and accurate identifi-
cation of the strain and an adequate anti-
microbial susceptibility testing. 
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